Negative serology of Fasciola hepatica infection in patients with liver cancer in Peru: a preliminary report

AUTOR(ES)

Machicado, Claudia, Bertani, Stéphane, Herrera-Velit, Patricia, Espinoza, Jose, Ruiz, Eloy, Marcos, Luis

FONTE

Rev. Soc. Bras. Med. Trop.

DATA DE PUBLICAÇÃO

2018-04

RESUMO

Abstract INTRODUCTION: The etiology of several hepatocellular carcinoma (HCC) cases remains largely unknown. Although Fasciola hepatica has been associated with liver fibrosis in Latin America, it has not yet been associated with HCC. This study aimed to determine the existence of specific IgG antibodies against F. hepatica in the serum samples of HCC patients. METHODS In total, 13 serum samples from 13 HCC patients were screened using Fas2-ELISA. RESULTS Fas2-ELISA demonstrated negative results in all HCC patients included in this study. CONCLUSIONS The pre-existence of F. hepatica infection in HCC patients needs to be further investigated in epidemiological and experimental studies.

Documentos Relacionados

• Fascioliasis in relatives of patients with Fasciola hepatica infection in Peru
• Incidence of Chronic Genital Infection in Male Patients with Uveitis*: A PRELIMINARY REPORT
• Pseudo-Chancre Redux with Negative Serology: A CASE REPORT*
• Study of surface carbohydrates in Galba truncatula tissues before and after infection with Fasciola hepatica
• Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen